Icodex Publish Stock Price Today (NSE: 544483)

Icodex Publish

38.95+0.00 (+0.00%)
Market Closed

Fundamental Score

...

Icodex Publish Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Icodex Publish share price today is 38.95, up +0.00% on NSE/BSE as of 30 September 2025. Icodex Publish (544483) is a Small-cap company in the IT Enabled Services sector with a market capitalisation of 60.91 (Cr). The 52-week high for 544483 share price is N/A and the 52-week low is N/A. At a P/E ratio of 8.59x, 544483 is currently trading below its industry average P/E of 27.70x. The company has a Return on Equity (ROE) of 18.82% and a debt-to-equity ratio of 0.13.

Icodex Publish Share Price Chart — NSE/BSE Historical Performance

No data
High
38.95
Low
38.95
Volume
0
Change
+0.00%

Icodex Publish share price chart: 0.00% return over the past month. 52-week high ₹N/A, 52-week low ₹N/A.

Returns & Performance

Good

Return on Equity (ROE)

18.82%

Profit generated per ₹1 of shareholder equity

Excellent

Return on Capital (ROCE)

24.87%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

42.28%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Icodex Publish Valuation Check

Excellent

Price to Earnings (P/E)

8.59x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

27.70x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

64.44%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.01%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-65.66%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

9.16%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

39.21%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-78.51%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

48.25%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.13x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

29.50x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-15.79 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Icodex Publish Fundamental Analysis & Valuation Benchmarking

Educational evaluation of 544483 across key market metrics for learning purposes.

Positive Indicators

10 factors identified

Strong Return on Equity (18.82%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (24.87%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Strong Operating Margins (42.28%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Attractive Valuation (P/E: 8.59 vs Industry: 27.70)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Consistent Growth Track Record (39.21% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Strong Profit Growth Track Record (48.25% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Conservative Debt Levels (D/E: 0.13)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (29.50x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Balanced Promoter Holding (64.44%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

5 factors identified

Profit Decline Concern (-65.66%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Weak Earnings Growth (-78.51% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Negative Free Cash Flow (₹-15.79 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Limited Institutional Interest (FII+DII: 0.01%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Icodex Publish vs IT Enabled Services Peers

Peer Comparison - IT Enabled Services

Compare Icodex Publish with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
61/100
39
₹60.91
8.6
Average
18.82%
Good
24.87%
Excellent
0.1
Excellent
48.25%
Excellent
39.21%
Excellent
0.00%
64.8/100
3555
₹37231.27
27.7
Average
21.53%
Excellent
26.71%
Excellent
0.1
Excellent
15.78%
Excellent
15.07%
Excellent
1.65%
65.9/100
1849
₹32213.44
44.6
Average
40.32%
Excellent
36.86%
Excellent
0.3
Excellent
34.25%
Excellent
42.03%
Excellent
0.00%
59.1/100
748
₹30817.30
50.3
Average
16.34%
Good
20.90%
Excellent
0.2
Excellent
20.78%
Excellent
18.25%
Excellent
1.10%
67.1/100
4524
₹24894.73
121.0
Average
32.84%
Excellent
37.50%
Excellent
0.4
Excellent
90.38%
Excellent
72.54%
Excellent
0.06%
67.3/100
1586
₹21135.57
46.5
Average
13.79%
Average
16.84%
Good
0.0
Excellent
27.54%
Excellent
39.29%
Excellent
0.00%
54.7/100
43
₹19637.96
20.7
Average
10.54%
Average
13.37%
Average
0.1
Excellent
0.12%
42.8/100
756
₹15506.23
56.5
Average
26.84%
Excellent
22.20%
Excellent
0.9
Good
13.73%
Good
6.23%
Good
0.11%
Cyient Ltd...
CYIENT532175
28.8/100
848
₹9344.05
19.7
Average
8.61%
Poor
12.28%
Average
0.1
Excellent
5.40%
Good
11.96%
Good
3.10%
22.6/100
517
₹8458.45
-0.95%
Poor
-0.51%
Poor
0.1
Excellent
47.40%
Excellent
0.00%
63.5/100
1260
₹5101.67
17.9
Average
25.96%
Excellent
34.09%
Excellent
0.0
Excellent
12.67%
Good
18.23%
Excellent
0.00%

Icodex Publish Quarterly Performance

Latest quarterly metrics for 544483 — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

9.16%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-65.66%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

39.21%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

48.25%

Compounded annual net profit growth over 5 years

Icodex Publish Financial Statements

Annual income statement, balance sheet and cash flow for Icodex Publish (544483) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Icodex Publish

About 544483 (Icodex Publish)

Icodex Publish (544483) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the IT Enabled Services sector with a curre...nt market capitalisation of ₹60.91 (Cr). Icodex Publish has delivered a Return on Equity (ROE) of 18.82% and a ROCE of 24.87%. The debt-to-equity ratio stands at 0.13, reflecting the company's capital structure. Investors tracking 544483 share price can monitor key metrics including P/E ratio, promoter holding of 64.44%, and quarterly earnings growth.

Company Details

Symbol:544483
Industry:IT Enabled Services
Sector:IT Enabled Services
Website:N/A

544483 Share Price: Frequently Asked Questions

What is the current share price of Icodex Publish?

Icodex Publish (544483) trades at ₹38.95 on BSE. Market cap ₹60.91 (Cr). Educational data only.

What is the P/E ratio of Icodex Publish?

Icodex Publish has a P/E of 8.59x vs industry average 27.70x.

What is the Bull Run score for Icodex Publish?

Icodex Publish has a Bull Run score of 61/100 based on 25+ financial parameters.

Does Icodex Publish pay dividends?

Icodex Publish has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Icodex Publish?

Icodex Publish has ROE of 18.82%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Icodex Publish?

Icodex Publish has debt-to-equity of 0.13.

Is Icodex Publish a good investment?

Bull Run gives Icodex Publish a score of 61/100. This is not investment advice — consult a SEBI-registered advisor.